Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans
- PMID: 31229189
- PMCID: PMC6815097
- DOI: 10.1016/j.jsat.2019.05.007
Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans
Abstract
Background: Substance use disorders (SUDs) are common in healthcare settings and contribute to poor outcomes, particularly in patients living with HIV. We assessed initiation, engagement, and retention in SUD treatment and pharmacotherapy following an index SUD episode in a national sample of HIV-infected and uninfected patients receiving care in the Department of Veterans Affairs (VA) healthcare system.
Methods: We used electronic national VA data (years 2000-2015) from 52,995 HIV-infected and 111,229 age-, race-, gender-, and region-matched uninfected patients. We defined index SUD episodes as outpatient visits or inpatient/residential admissions with associated primary or secondary ICD-9 codes for substance use in patients without SUD-related services or pharmacotherapy in the preceding 5 months.
Results: Overall, 57,428 (35%) patients had at least 1 index SUD episode. HIV-infected patients were more likely than uninfected controls to have at least one index SUD episode (35.7% vs. 34.6%; p < .001). Rates of initiation, engagement, and retention in SUD treatment after the index SUD episode were <17% for both groups. In adjusted models, HIV-infected patients were more likely than uninfected patients to be retained in SUD treatment at 6 months (Odds Ratio 1.10; 95% Confidence Interval 1.04-1.16). SUD pharmacotherapy initiation and engagement was uncommon in both HIV-infected and uninfected patients.
Conclusions: In this national VA sample, initiation of SUD treatment and pharmacotherapy were uncommon for both HIV-infected and uninfected patients. Interventions to improve initiation, engagement, and retention in the full range of services, including SUD pharmacotherapy, are warranted for all patients with SUD in the VA.
Keywords: HIV; Opioid treatment; Pharmacotherapy; Substance use disorder treatment; Substance use disorders.
Copyright © 2019 Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures
Similar articles
-
Gender differences in service utilization among Operations Enduring Freedom, Iraqi Freedom, and New Dawn Veterans Affairs patients with severe mental illness and substance use disorders.Psychol Serv. 2018 Feb;15(1):11-20. doi: 10.1037/ser0000144. Epub 2017 May 18. Psychol Serv. 2018. PMID: 28517950
-
High inpatient utilization among Veterans Health Administration patients with substance-use disorders and co-occurring mental health conditions.Am J Drug Alcohol Abuse. 2018;44(3):386-394. doi: 10.1080/00952990.2017.1381701. Epub 2017 Nov 2. Am J Drug Alcohol Abuse. 2018. PMID: 29095057 Free PMC article.
-
Impact of implementing a tobacco and recreational nicotine-free policy and enhanced treatments on programmatic and patient-level outcomes within a residential substance use disorder treatment program.J Subst Abuse Treat. 2019 Dec;107:44-49. doi: 10.1016/j.jsat.2019.09.004. Epub 2019 Oct 5. J Subst Abuse Treat. 2019. PMID: 31757264
-
Evidence-based screening, diagnosis, and treatment of substance use disorders among veterans and military service personnel.Mil Med. 2012 Aug;177(8 Suppl):29-38. doi: 10.7205/milmed-d-12-00125. Mil Med. 2012. PMID: 22953439 Review.
-
Suicide and substance use among female veterans: a need for research.Drug Alcohol Depend. 2014 Mar 1;136:1-10. doi: 10.1016/j.drugalcdep.2013.11.009. Epub 2013 Nov 20. Drug Alcohol Depend. 2014. PMID: 24315571 Free PMC article. Review.
Cited by 12 articles
-
Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United States.Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109110. doi: 10.1016/j.drugalcdep.2021.109110. Epub 2021 Sep 28. Drug Alcohol Depend. 2021. PMID: 34700145
-
Impact of intensity of behavioral treatment, with or without medication treatment, for opioid use disorder on HIV outcomes in persons with HIV.J Subst Abuse Treat. 2022 Jan;132:108509. doi: 10.1016/j.jsat.2021.108509. Epub 2021 May 29. J Subst Abuse Treat. 2022. PMID: 34130128
-
"It's like a Brotherhood": Thematic analysis of veterans' identity processes in substance abuse recovery homes.J Community Psychol. 2021 Aug;49(6):1531-1553. doi: 10.1002/jcop.22623. Epub 2021 Jun 11. J Community Psychol. 2021. PMID: 34114649
-
Social Network Cohesion among Veterans Living in Recovery Homes.Mil Behav Health. 2021;9(1):55-68. doi: 10.1080/21635781.2020.1796859. Epub 2020 Aug 3. Mil Behav Health. 2021. PMID: 34109074 Free PMC article.
-
A missed opportunity: underutilization of inpatient behavioral health services to reduce injection drug use sequelae in Florida.Subst Abuse Treat Prev Policy. 2021 May 31;16(1):46. doi: 10.1186/s13011-021-00383-w. Subst Abuse Treat Prev Policy. 2021. PMID: 34059104 Free PMC article.